galactosamine has been researched along with 3-hydroxyflavone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, W; Gao, HY; Huang, J; Li, GY; Li, PY; Tan, Y; Wang, HY; Wang, JH; Xie, SA; Zhang, K; Zheng, YX | 1 |
| Liu, Z; Shen, Z; Tian, Q; Wang, G; Yang, L; Zhang, F; Zhang, Y | 1 |
2 other study(ies) available for galactosamine and 3-hydroxyflavone
| Article | Year |
|---|---|
A new flavanol from Cynomorium songaricum.
Topics: Cynomorium; Drugs, Chinese Herbal; Flavonols; Galactosamine; Hep G2 Cells; Humans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Stems | 2013 |
Engeletin inhibits Lipopolysaccharide/d-galactosamine-induced liver injury in mice through activating PPAR-γ.
Topics: Animals; Chemical and Drug Induced Liver Injury; Flavonols; Galactosamine; Glycosides; Interleukin-1beta; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; NF-kappa B; PPAR gamma; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |